ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
2019年06月04日 16時00分
Source:
Eisai
エーザイ、人事異動ならびに組織改編を発表
東京, 2019年06月04日 - (JCN Newswire) - エーザイ株式会社は本日、人事異動ならびに組織改編(2019年6月1日付)を以下のとおり発表しました。
2019年6月1日付 人事異動
■グローバル本社
新任務/旧任務/氏名
コーポレートベンチャーインベストメント部 ストラテジックインベストメントオフィサー(理事職)/(入社)/有賀 学
2019年6月1日付 主な組織改編
■ グローバル本社
1. ストラテジックインベストメントオフィサーの設置
コーポレートベンチャーインベストメント(CVI)部に、ストラテジックインベストメントオフィサー(SIO)を設置する。SIOは、CVIプロジェクトを主導するとともに、チーフストラテジーオフィサーおよびチーフフィナンシャルオフィサーと連携し、投資戦略立案ならびに投資先候補の選定を担う。
本リリースの詳細は下記をご参照ください。
https://www.eisai.co.jp/news/2019/news201941.html
概要:エーザイ株式会社
詳細はwww.eisai.co.jpをご覧ください。
Source: Eisai
セクター: バイオテック
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Olympus Enters Strategic Partnership to Develop Endoluminal Gastrointestinal Robotics
Jul 25, 2025 16:00 JST
Eisai Listed for 24th Consecutive Year in FTSE4Good Index Series, an Index for Socially Responsible Investment
Jul 25, 2025 13:31 JST
Fujitsu and Nagoya University develop simulation tech to combat transportation gaps
Jul 24, 2025 12:30 JST
Honda Reveals Details of its Support of the World Athletics Championships Tokyo 25
Jul 24, 2025 12:03 JST
Prototype divertor outer vertical target for the ITER fusion experimental reactor is completed and the sample has passed the ITER Organization's certification test
Jul 23, 2025 13:10 JST
Sharp Exhibits at the 2nd SPEXA - International Space Business Expo
Jul 23, 2025 10:30 JST
Launch of Beova(R) Tablets in Thailand for Overactive Bladder
Jul 23, 2025 10:07 JST
Crown Bioscience San Diego Achieves CLIA Certification to Enhance Clinical Trial Support
Jul 23, 2025 10:00 JST
Mitsubishi Motors to Terminate Its Joint Venture Partnership with Shenyang Aerospace Mitsubishi Motors Engine Manufacturing
Jul 22, 2025 17:00 JST
Eisai To Present Four-Year Efficacy And Safety Data On Continuous Treatment With Lecanemab At The Alzheimer's Association International Conference 2025
Jul 22, 2025 11:56 JST
Anime Tokyo Station TV Anime "SPYxFAMILY" Special Exhibition
Jul 22, 2025 11:00 JST
ShrimpTech JIRCAS and IMT Engineering Announce Strategic Collaboration to Advance Land-Based Aquaculture
Jul 22, 2025 09:00 JST
Honda Koraidon First Showrun during Suzuka 8 Hours
Jul 18, 2025 11:06 JST
SJC2 optical submarine cable in operation
Jul 18, 2025 09:36 JST
MHI-AP Awarded Long-term Service Contract for the Garabogazkarbamid Fertilizer Plant in Turkmenistan
Jul 17, 2025 19:07 JST
Mitsubishi Motors Premieres the All-New Destinator in Indonesia
Jul 17, 2025 17:21 JST
Hitachi, global investment firm Brookfield, and global commodities trading firm Hartree Begin to Explore a Funding Scheme in the Environmentally-friendly Digital Infrastructure Sector
Jul 17, 2025 14:16 JST
"TOKIO Exciting Anime Workshop" Confirmed - Enjoy "Summer Festival at Anime Tokyo Station" This Summer Vacation
Jul 17, 2025 11:00 JST
Eisai Awarded "The 9th Bioindustry Award" for Drug Discovery Research for Anti- Amyloid B Monoclonal Antibody Lecanemab
Jul 16, 2025 14:50 JST
New Trains for Singapore's Sengkang-Punggol LRT Begin Commercial Operation
Jul 16, 2025 14:34 JST
More Latest Release >>
Related Release
Eisai Listed for 24th Consecutive Year in FTSE4Good Index Series, an Index for Socially Responsible Investment
7/25/2025 1:31:00 PM JST
Launch of Beova(R) Tablets in Thailand for Overactive Bladder
7/23/2025 10:07:00 AM JST
Eisai To Present Four-Year Efficacy And Safety Data On Continuous Treatment With Lecanemab At The Alzheimer's Association International Conference 2025
7/22/2025 11:56:00 AM JST
Eisai Awarded "The 9th Bioindustry Award" for Drug Discovery Research for Anti- Amyloid B Monoclonal Antibody Lecanemab
7/16/2025 2:50:00 PM JST
"URECE" (Dotinurad) Launched in China as a treatment for Gout
7/14/2025 10:20:00 AM JST
Eisai Selected as Supplier Engagement Leader, CDP's Highest Rating in the Supplier Engagement Assessment
7/8/2025 9:31:00 AM JST
Eisai to Launch "Pariet S," the First Proton Pump Inhibitor RX-to-OTC in Japan
6/2/2025 5:46:00 PM JST
New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO (Lemborexant) in China
5/28/2025 5:45:00 PM JST
Eisai Demonstrates Commitment to Oncology Innovation at ASCO 2025
5/21/2025 3:00:00 PM JST
Eisai Satisfies All-Case Surveillance Requirement for Anticancer Agent Remitoro
5/16/2025 5:21:00 PM JST
More Press release >>